Role of cholesterol ester mass in regulation of secretion of apoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 743-752

  Zhang, Zujun ^a   Cianflone, Katherine ^a   Sniderman, Allan D ^a,b  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Cholesterol ester; Hepatocytes; Lipoprotein

Indexed keywords

APOLIPOPROTEIN B100; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; MEVINOLIN; STATIN;

ANIMAL CELL; ARTICLE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; LIVER CELL; LIVER CELL CULTURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN SECRETION; SYRIAN HAMSTER;

EID: 0033012561     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.743     Document Type: Article

References (39)

1. Sniderman AD, Brown BG, Stewart FF, Cianflone K. From familial combined hyperlipidemia to hyperapoB: unraveling overproduction of hepatic apoB lipoproteins. Curr Opin Lipidol. 1992;3:137-142.
2. Yao Z, Tran K, Mcleod RS. Intracellular degradation of newly synthesized apolipoprotein B. J Lipid Res. 1997;38:1937-1953.
3. Thompson GR, Naoumova RP, Watts GF. Role of cholesterol in regulating apolipoprotein B secretion by the liver. J Lipid Res. 1996;37: 439-447.
4. Sato R, Imanaka T, Takano T. The effect of HMG-CoA reductase inhibitor (CS-514) on the synthesis and secretion of apolipoproteins B and A-1 in the human hepatoblastoma Hep G2. Biochim Biophys Acta. 1990;1042: 36-41.
5. Furukawa S, Hirano T. Rapid stimulation of apolipoprotein B secretion by oleate is not associated with cholesteryl ester biosynthesis in HepG2 cells. Biochim BiophysActa. 1993;1170:32-37.
6. Wu X, Sakata N, Lui E, Ginsberg HN. Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester. J Biol Chem. 1994;269: 12375-12382.
7. Graham A, Wood JL, Russell LJ. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells. Biochim Biophys Acta. 1996;1302:46-54.
8. Benoist F, Grand-Perret T. ApoB-100 secretion by HepG2 cells is regulated by the rate of triglyceride biosynthesis but not by intracellular lipid pools. Arterioscler Thromb Vasc Biol. 1996;16:1229-1235
9. Cianflone K, Yasruel Z, Rodriguez MA, Vas D, Sniderman AD. Regulation and apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge. J Lipid Res. 1990;31:2045-2055.
10. Cianflone K, Dahan S, Monge JC, Sniderman AD. Pathogenesis of carbohydrate induced hypertriglyceridemia using HepG2 cells as a model system. Arterioscler Thromb. 1992;12:271-277.
11. Gibbons GF, Khurana R, Odwell A, Seelaender MCL. Lipid balance in HepG2 cells: active synthesis and impaired mobilization. J Lipid Res. 1994;35:1801-1808
12. Swift LL. Assembly of very low density lipoproteins in rat liver: a study of nascent particles recovered from the rough endoplasmic reticulum. J Lipid Res. 1995;36:395-406.
13. Rusinol A, Verkade H, Vance JE. Assembly of rat hepatic very low density lipoproteins in the endoplasmic reticulum. J Biol Chem. 1993; 268:3555-3562.
14. Liu GL, Fan LM, Redinger RN. The association of hepatic apoprotein and lipid metabolism in hamsters and rats. Comp Biochem Physiol. 1991;99a: 223-228.
15. Arbeeny CM, Myers DS, Bergquist RE, Gregg RE. Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. J Lipid Res. 1992;33:843-851.
16. Spady DK, Dietschy J. Dietary saturated triacylglycerols suppress hepatic low density lipoprotein receptor activity in the hamster. Proc Natl Acad Sci U S A. 1985;82:4526-4530.
17. Hoang VQ, Pearce NJ, Suckling KE, Botham KM. Evaluation of cultured hamster hepatocytes as an experimental model of the study of very low density lipoprotein secretion. Biochim Biophys Acta. 1995;1254:37-44.
18. Salter AM, Sessions VA. LDL binding to hepatocytes isolated from hamsters fed different dietary fatty acids. Biochem Soc Trans. 1993; 21:150S.
19. Hoang VQ, Botham K, Pearce NJ, Suckling KE. The regulation of bile acid synthesis in cultured hamster hepatocytes. Biochem Soc Trans. 1993;21:2848.
20. Sniderman AD, Zhang Z, Cianflone K. Divergent responses of the liver to increased delivery of glucose or fatty acids: implications for the pathogenesis of type IV hyperlipoproteinemia. Atherosclerosis. 1998; 137:291-301.
21. Van Harken DR, Dixon CW, Heimberg M. Hepatic lipid metabolism in experimental diabetes V: the effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J Biol Chem. 1969;244: 2278-2285.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities or protein utilizing the principal of protein-dye binding. Anal Biochem. 1976;72:248-254.
23. Neri BP, Frings CS. Improved method for determination of triglycerides in serum. Clin Chem. 1973;19:1201-1202.
24. Rudel LL, Morris MD. Determination of cholesterol using o-phthalaldehyde. J Lipid Res. 1973;14:364-366.
25. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
26. Marais AD, Naoumova RP, Firth JC, Penny C, Neuwirth CK, Thompson GR. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia. J Lipid Res. 1997;38:2071-2078.
27. Raal F, Pilcher GJ, Illingworth DR, Pappu AS, Stein EA, Laskarzewski P, Mitchel YB, Melino MR. Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia. Atherosclerosis. 1997;135: 249-256.
28. Bisgaier CL, Essenburg AD, Auerbach BJ, Pape ME, Sekerke CS, Gee A, Wolle S, Newton RS. Attenuation of plasma low density lipoprotein cholesterol by select 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors in mice devoid of low density lipoprotein receptors. J Lipid Res. 1997;38:2502-2515.
29. Shiomi M, Shiraishi M, Yata T, Ito T. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels. Drug Res. 1994;44:1154-1156.
30. Tanaka M, Jingami H, Otani H, Cho M, Ueda Y, Arai H, Nagano Y, Doi T, Yokode M, Kita T. Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester content in rabbit hepatocytes. J Biol Chem. 1993;268:12713-12718.
31. Mohammadi A, Macri J, Newton R, Romain T, Dulay D, Adeli K. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells. Arterioscler Thromb Vasc Biol. 1998;18: 783-793.
32. Watts GF, Naoumova R, Cummings MH, Umpleby, AM, Slavin BM, S246šnksen PH, Thompson GR. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects. Metabolism. 1995;44:1052-1057.
33. Watts GF, Naoumova RP, Kelly JM, Riches FM, Croft KD, Thompson GR. Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects. Am J Physiol 1997;273: E462-E470.
34. Cummings MH, Watts GF, Pal C, Umpleby M, Hennessy TR, Naoumova R, S246šnksen PH. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in obesity: a stable isotope study. Clin Sci. 1995;88:225-233.
35. Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, S246šnksen PH. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM. Diabetologia. 1995;38:959-967.
36. Goh EH, Heimberg M. Stimulation of hepatic cholesterol biosynthesis by oleic acid. Biochem Biophys Res Commun. 1973;55:382-388.
37. Goh EH, Heimberg M. Effects of free fatty acids on activity of hepatic microsomal 3-hydroxy-methylglutaryl coenzyme A reductase and on secretion of cholesterol and triglyceride by the liver. J Biol Chem. 1977; 252:2822-2826.
38. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-37.
39. Havekes LM, DeWit ECM, Prince HNG. Cellular free cholesterol in HepG2 cells is only partially available for down-regulation of low-density-lipoprotein receptor activity. Biochem J. 1987;247:739-746.